2021 ISPE Aseptic Virtual Conference

Setting the Pace for 30 Years!

Mark your calendar for the 30th Anniversary of the ISPE Aseptic Conference being held on 15–17 March 2021.

The ISPE Aseptic Conference has been setting the pace for the evolution of sterile manufacturing processes and technologies in the pharmaceutical industry for 30 years. The virtual conference platform will provide a unique opportunity for expanded global participation, both by speakers and attendees. In addition to addressing recurring issues in aseptic processing, this year’s regulatory updates and panel discussions will focus on Annex 1 updates, accelerated efforts for manufacturing of vaccines, supply chain disruptions, and the impact of the pandemic on sterile manufacturing operations. Industry case studies and lessons learned will include successful applications for ATMP/cell & gene therapy facilities and manufacturing, automation for improved sterility assurance and containment for increased throughput, innovative bio decontamination approaches, aseptic filling for combination products, H2O2 applications, bioprocessing quality risk management, and next-level ADC processing. The program content will be available to all registered attendees for a full year following the event. 

Conference Topics:

  • COVID-19 Impact 
  • Annex 1 Update for Barrier Technologies 
  • Aseptic Process Innovations 
  • Advanced Therapy Medicinal Products (ATMPs)
  • Containment
  • Robotics in Aseptic and Barrier Applications 
  • H2O2 Applications in Aseptic Processing
  • Single Use Technology Advancements
  • Viral Vaccine Production

Learning Objectives:

  • Apply the latest developments in sterile processing science and technology 
  • Implement robotic applications for ATMP and cell & gene therapy production 
  • Work with highly potent/toxic products for GMP and Occupational Safety 
  • Understand best-practice Quality Risk management approaches

Featured Speakers

Why Attend Virtually

  • Feel like You're In-Person with a Fully Interactive Digital Experience
    Our event portal is easy to navigate and will allow you to view presentations, access PDFs of the presentations, take downloadable notes in each session, participate in polls, chat with other attendees, and participate in LIVE Q&A sessions with speakers.
    alt 1
  • Build Your Experience
    Add the sessions you want to attend with the click of a button to build your own custom agenda. Interested in two sessions happening at the same? We have you covered because you'll have access to all of the recordings from the event for one year.
    alt 2
  • Gain Actionable Insights
    Global experts will be at your fingertips sharing their knowledge and lessons learned on advanced therapeutic medicinal products (ATMPs) including cell and gene therapies, digitalization, single-use technology, implications of ICH Q12 for biopharma, and much more.
    alt 3
  • Stay Current and Knowledgeable Throughout the Year
    In addition to expert insights, your tangible takeaways include access to the recording of ALL conference sessions and presentations for one year. Unlike an in-person event, you’ll get to experience the sessions you missed—that means both tracks! The recordings are also valuable as a refresher throughout the year.
    alt  4

Virtual Event FAQs

Receive Notifications

Stay up-to-date on registration, education opportunities, speakers, hotel discounts, exhibitor information, and more by signing up to receive notifications for the 2021 ISPE Aseptic Conference.

Company Type

Program Committee

Joerg Zimmermann
Vice President, Vetter Development Service, External Affairs
Vetter Pharma-Fertigung GmbH & Co.
David Doleski
Compliance Head for Biologics Quality Operations
Richard Denk
Senior Consultant Aseptic Processing & Containment
Dina Manfredi
Project Engineer
GMP Systems Inc
Christa B. Myers
Pharmaceutical Market Director
Klaus Ullherr
Senior Product Manager
Syntegon Technology GmbH
Keith W. Weseli, CPIP
Director of Operations, Midwest Region
Eric S. Thostesen
Senior Director Regulatory Compliance
Johnson & Johnson
Michael G. Higgins
Senior Compliance Advisor